These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11569227)

  • 21. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Case studies of bacterial species responsible for urinary tract infections and their sensitivity to antibiotic treatment].
    Dominici C; Morozzi B
    Minerva Chir; 1978 Dec 15-31; 33(23-24):1745-62. PubMed ID: 740260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic study of nosocomial bacterial infection of pediatric patients at BMA Medical College and Vajira Hospital.
    Tantracheewathorn T; Vititpatarapak N; Phumisantiphong U
    J Med Assoc Thai; 2007 Feb; 90(2):258-65. PubMed ID: 17375629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report].
    Schmid W
    Med Welt; 1980 Jan; 31(1):32-6. PubMed ID: 6770223
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current status of determining bacteria and resistance in urinary tract infections].
    Ritzerfeld W; Fegeler W
    Urologe A; 1984 May; 23(3):130-3. PubMed ID: 6539985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary tract infections in children--etiologic agents and susceptibility to antibiotics].
    Nowakowska M; Rogala-Zawada D; Wiechuła B; Rudy M; Radosz-Komoniewska H; Zientara M
    Wiad Lek; 2004; 57(9-10):438-43. PubMed ID: 15765758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of urinary infection with cephadroxyl (Pharmachem)--microbiological and clinical research].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1987; 26(5):98-104. PubMed ID: 3433735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pipemidinic acid as a urinary antiseptic--microbiological and clinical study].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1985; 24(5):46-53. PubMed ID: 4090453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility pattern of urinary tract pathogens.
    Khameneh ZR; Afshar AT
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):251-3. PubMed ID: 19237813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial resistance to antibiotics used to treat urinary tract infections in Mexican children.
    Hernández-Porras M; Salmerón-Arteaga G; Medina-Santillán R
    Proc West Pharmacol Soc; 2004; 47():120-1. PubMed ID: 15633630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections].
    Cisowska A; Lewczyk E; Korzekwa K; Wojnicz D; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2003 Apr; 14(82):322-6. PubMed ID: 12868193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of complicated urinary tract infections].
    Naber KG
    Wien Med Wochenschr; 1991; 141(23-24):552-5. PubMed ID: 1810095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of urologic infections with cefamandole (Pharmachim)--the microbiological and clinical results].
    Minkov N; Zlatanov Z; Zozikov B; Khristova D
    Vutr Boles; 1986; 25(4):32-8. PubMed ID: 3765588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
    Durnaá B; Dzierzanowska D
    Wiad Lek; 2006; 59(7-8):506-11. PubMed ID: 17209349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects.
    Velasco E; Byington R; Martins CS; Schirmer M; Dias LC; Gonçalves VM
    Clin Microbiol Infect; 2004 Jun; 10(6):542-9. PubMed ID: 15191383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Microbial spectrum in chronic pyelonephritis and the drug sensitivity of the microorganisms].
    Gruev I; Lobutova M; Markova B; Neshev Kh; Robeva R
    Vutr Boles; 1985; 24(3):33-8. PubMed ID: 4024620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.